Am I wrong to read this as a reference to Fusion (a recent US$1.4billion buyout by Astra Zeneca)!"... Alpha-emitter therapies, such as those involving actinium-225 (Ac-225or 225Ac) and lead-212 (Pb-212 or 212Pb), are generatinginterest,BUT;
a) Their commercialsupply chains are still in the early development phase, and they arecurrently very difficult to source.
b) They are YET TOSHOWsafety and efficacy in late-stage trials, as opposed to betaemitters, like Cu-67, that have a long history of effectiveness in treatingsolid tumors...."
If so (and I think it is) - GREAT!![]()
- Forums
- ASX - By Stock
- Ann: Clarity enters into Clinical Supply Agreement
Am I wrong to read this as a reference to Fusion (a recent...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
|
|||||
Last
$7.23 |
Change
0.560(8.40%) |
Mkt cap ! $2.280B |
Open | High | Low | Value | Volume |
$6.81 | $7.42 | $6.77 | $85.37M | 11.80M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3000 | $7.21 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.26 | 72772 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3000 | 7.210 |
1 | 1993 | 7.170 |
1 | 7768 | 7.150 |
1 | 29262 | 7.130 |
1 | 7768 | 7.120 |
Price($) | Vol. | No. |
---|---|---|
7.260 | 72772 | 1 |
7.280 | 29262 | 1 |
7.290 | 101435 | 7 |
7.300 | 25496 | 2 |
7.320 | 7768 | 2 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online